I2I Apr. 25, 2016 – FDA 101
The Office of Technology Commercialization
Invention 2 Innovation (I2I)
“FDA 101: ‘Why, What, and How To’ of Drug Devleopment”
Monday, April 25, 2016
12:00 pm – 1:30 pm
Leavey Program Room at the Leavey Center (Across from the bookstore.)
Dr. Jesse L. Goodman, M.D., M.P.H.
Georgetown University School of Medicine
Dr. Goodman, a renowned expert in infectious diseases, is the founding director of the Center on Medical Product Access, Safety and Stewardship (COMPASS) at Georgetown. He is a member of the Institute of Medicine and was most recently Chief Scientist of the Food and Drug Administration (FDA) (from 2009 until February 2014) where he also founded and co- chaired the first U.S. Task Force to Combat Antimicrobial Resistance and directed the Center for Biologics Evaluation and Research. He worked extensively with industry, academia, government and global public health partners to prepare for and respond to major public health threats including bioterrorism and West Nile Virus, and led the FDA’s response to the 2009 H1N1 pandemic.
Lunch will be provided, space is limited.
Please RSVP by Friday, April 22, 2016
to Jeremy S. Alexander at jsa28 at georgetown dot edu or 202.687.7424.
Faculty, entrepreneurs, fellows, business students, medical students, law students and research administrators are encouraged to attend.